These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Rationale for prescribing oral contraceptives]. Teichmann AT Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865 [TBL] [Abstract][Full Text] [Related]
26. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Dallenbach-Hellweg G Pathol Res Pract; 1984 Sep; 179(1):38-50. PubMed ID: 6504768 [TBL] [Abstract][Full Text] [Related]
27. Bloody nipple discharge in children: possible etiologies and selection of appropriate therapy. Imamoglu M; Cay A; Reis A; Ozdemir O; Sapan L; Sarihan H Pediatr Surg Int; 2006 Feb; 22(2):158-63. PubMed ID: 16328337 [TBL] [Abstract][Full Text] [Related]
28. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304 [TBL] [Abstract][Full Text] [Related]
29. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435 [TBL] [Abstract][Full Text] [Related]
30. [Clinical aspects of the administration of gestagen preparations (Volidan, Cyclofarlutal, Ovulen, Ciba AC-101 and Steridil)]. Sternadel Z Ginekol Pol; 1970 Jul; 41(7):771-6. PubMed ID: 5453644 [TBL] [Abstract][Full Text] [Related]
31. Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. LiVolsi VA; Stadel BV; Kelsey JL; Holford TR; White C N Engl J Med; 1978 Aug; 299(8):381-5. PubMed ID: 566853 [TBL] [Abstract][Full Text] [Related]
32. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
33. [Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA]. Beck R; Heywang SH; Eiermann W; Permanetter W; Lissner J Digitale Bilddiagn; 1987 Dec; 7(4):167-9. PubMed ID: 3436118 [TBL] [Abstract][Full Text] [Related]
34. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports. Hawley W; Nuovo J; DeNeef CP; Carter P J Am Board Fam Pract; 1993; 6(2):123-35. PubMed ID: 8452064 [TBL] [Abstract][Full Text] [Related]
35. The relationship of estrogen and progesterone to breast disease. Brooks PG J Reprod Med; 1984 Jul; 29(7 Suppl):530-8. PubMed ID: 6481706 [TBL] [Abstract][Full Text] [Related]
36. [Which are the commonest questions about contraceptives and how shall we answer them?]. Janson PO Jordemodern; 1990 May; 103(5):167-70. PubMed ID: 2365600 [TBL] [Abstract][Full Text] [Related]
37. [What do oral contraceptives do? What are oral contraceptives?]. Rignell S Nord Med; 1971 Oct; 86(40):1168. PubMed ID: 5131957 [TBL] [Abstract][Full Text] [Related]
38. Advantages and challenges of oestrogen-free hormonal contraception. Ahrendt HJ; Adolf D; Buhling KJ Curr Med Res Opin; 2010 Aug; 26(8):1947-55. PubMed ID: 20569066 [TBL] [Abstract][Full Text] [Related]
39. [Morphofunctional features of the cervix uteri in women using hormonal contraception]. Prilepskaia VN; Kondrikov NI; Nazarova NM Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353 [TBL] [Abstract][Full Text] [Related]
40. User characteristics and oral contraceptive compliance in Egypt. Trottier DA; Potter LS; Taylor BA; Glover LH Stud Fam Plann; 1994; 25(5):284-92. PubMed ID: 7871553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]